Shaloo Pandhi

Shaloo Pandhi is a seasoned professional in patient safety and clinical development, currently serving as the Global Head of Patient Safety at Sandoz since August 2021. With an extensive background at Novartis from November 2007 to December 2022, Shaloo held various roles including Head of Patient Safety, Sr Global Program Clinical Head, and Global Program Medical Director, focusing on chronic pain development, safety assessments, and regulatory interactions. Prior experience includes managerial roles at Shantha Biotechnics Ltd and Fortis Clinical Research, complemented by an MBBS from Guru Nanak Dev University and an MD in Pharmacology from Shaney Institute of Health Sciences.